We speak for small biotech

Why We Speak

We explain the relevance of Nash, Hoare and others in explaining Gricean implicature and cheap talk. We also develop a general model to address cases where communication is not cooperative, i..e cases of deception as well as cases where there is common knowledge of different interests in speaker and hearer. Tow models, one qualitative and one quantitative are introduced.

How can we speak math?

It is likely that most people can communicate mathematics to a computer more effectively (rapidly and accurately) by speaking than they can by using a stylus on a computer tablet. This may seem surprising, but is our speculation based on trying various alternative input methods. An even better setup may be to speak and simultaneously use pointing or handwriting. Unfortunately, building a proper...

What Do We Mean When We Speak About Named Entities?

The concept of Named Entity (NE) has its origin in the Named Entity Recognition and Classification (NERC) tasks, an offspring of Information Retrieval systems, and became one of the main interest points in the Sixth and Seventh Message Understanding Conference (MUC-6, MUC-7) competitions, held back in 1995 and 1998 (Cinchor, 1997; Black, 1998). From then on, most competitions and programs inclu...

Why We Should Reject Biotech Patents from TRIPS

Questionnaire for a Biotech

How and when did your company start, and where are you located? NovaDigm was founded in 2005 by a group of investigators at the los Angeles Biomedical research institute (lA BioMed) and the Division of infectious Diseases at Harbor-UclA Medical center. The company received its first venture capital funding from Domain Associates in 2008 and established its corporate headquarters and laboratory ...